1547 |
Appropriateness in Imaging: Why We Need to Pay Attention |
John McB. Hodgson |
May. 13. 11 |
1546 |
How and Why to Assess the Coronary Microvasculature |
William F. Fearon |
May. 13. 11 |
1545 |
Will Drug-coated Balloons, Drug-coated Stents Shift the Paradigm for Femoropopliteal Lesion |
Mark W. Burket |
May. 13. 11 |
1544 |
The Promise of Tibial Drug-Coated Balloons |
Andrej Schmidt |
May. 13. 11 |
1543 |
Can Biodegradable Polymer DES Be Better than 2nd Generation DES? |
Gaku Nakazawa |
May. 13. 11 |
1542 |
Traditional and Novel Metal Alloys: Advantages, Disadvantages and Trends |
Juan F. Granada |
May. 13. 11 |
1541 |
Assessment of New Stent Designs: Can We Balance Ongoing Innovation & Safety Evaluation? |
Mitchell W. Krucoff |
May. 13. 11 |
1540 |
Plaque Profilings: Insights from the Culprit Plaques |
Cheol Whan Lee |
May. 13. 11 |
1539 |
New VH Findings: Plaque Stability and Lesion Risk |
M Pauliina Margolis |
May. 13. 11 |
1538 |
Not a Believer: All Plaques Are Potentially Vulnerable! |
Ron Waksman |
May. 13. 11 |